Company / Depreciation & Amortization
BioNexus Gene Lab Corp Depreciation & Amortization History
FY2019-FY2019 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$41.7K
FY2019
5-year range
-
FY2019-FY2019
Trend
-
vs FY2018
Sector context
Sector data unavailable
Latest sector comparison
What the data says
$41,714 in FY2019.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Company context
Key Data Points
- Altman Z-Score 5.27 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | $41.7K | - |
As of FY2019 · SEC Form 10-K · Last checked Jun 21, 2026